Cryptococcus neoformansgalactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cryptococcus neoformansgalactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 8, Pages 997-1005
Publisher
Future Medicine Ltd
Online
2011-08-16
DOI
10.2217/imt.11.86
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis
- (2011) Siu-Kei Chow et al. VACCINE
- Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia
- (2010) M W Harr et al. CELL DEATH AND DIFFERENTIATION
- Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo
- (2010) Allan Jefferson Guimarães et al. CELLULAR MICROBIOLOGY
- Galactoxylomannans from Cryptococcus neoformans VarietiesneoformansandgrubiiAre Structurally and Antigenically Variable
- (2010) Magdia De Jesus et al. EUKARYOTIC CELL
- Role of CD45 Signaling Pathway in Galactoxylomannan-Induced T Cell Damage
- (2010) Eva Pericolini et al. PLoS One
- Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans
- (2010) M. Desnos-Ollivier et al. mBio
- Polarization optical analysis of the surface structures of various fungi
- (2009) W. Gährs et al. ACTA HISTOCHEMICA
- The structure of Cryptococcus neoformans galactoxylomannan contains β-d-glucuronic acid
- (2009) Christian Heiss et al. CARBOHYDRATE RESEARCH
- CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells
- (2009) Michelle L. Hermiston et al. IMMUNOLOGICAL REVIEWS
- Involvement of Glycoreceptors in Galactoxylomannan-Induced T Cell Death
- (2009) Eva Pericolini et al. JOURNAL OF IMMUNOLOGY
- Galactoxylomannan-Mediated Immunological Paralysis Results from Specific B Cell Depletion in the Context of Widespread Immune System Damage
- (2009) M. De Jesus et al. JOURNAL OF IMMUNOLOGY
- The cytoplasmic tail of CD45 is released from activated phagocytes and can act as an inhibitory messenger for T cells
- (2008) S. Kirchberger et al. BLOOD
- Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand
- (2008) Suellen N. Villena et al. CELLULAR MICROBIOLOGY
- Capsular Localization of theCryptococcus neoformansPolysaccharide Component Galactoxylomannan
- (2008) Magdia De Jesus et al. EUKARYOTIC CELL
- CD45 Glycosylation controls T-cell life and death
- (2008) L A Earl et al. IMMUNOLOGY AND CELL BIOLOGY
- Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
- (2008) Magdia De Jesus et al. MEDICAL MYCOLOGY
- Bid Participates in Genotoxic Drug-Induced Apoptosis of HeLa Cells and Is Essential for Death Receptor Ligands' Apoptotic and Synergistic Effects
- (2008) Barbara Köhler et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation